Dollar General, Dollar Tree And 3 Stocks To Watch Heading Into Thursday

With US stock futures trading higher this morning on Thursday, some of the stocks that may grab investor focus today are as follows:

With US stock futures trading higher this morning on Thursday, some of the stocks that may grab investor focus today are as follows:

  • Wall Street expects Dollar General Corporation (NYSE:DG) to report quarterly earnings at $2.93 per share on revenue of $9.39 billion before the opening bell. Dollar General shares gained 0.8% to $249.35 in after-hours trading.
  • NVIDIA Corporation (NASDAQ:NVDA) reported weaker-than-expected results for its second quarter on Wednesday. Nvidia is guiding for third-quarter revenue of $5.9 billion plus or minus 2%. NVIDIA shares fell 4.6% to $164.38 in the after-hours trading session.
  • Analysts are expecting Dollar Tree, Inc. (NASDAQ:DLTR) to have earned $1.58 per share on revenue of $6.79 billion for the latest quarter. The company will release earnings before the markets open. Dollar Tree shares gained 0.9% to $167.47 in after-hours trading.

Check out our premarket coverage here

  • Salesforce Inc (NYSE:CRM) reported upbeat results for its second quarter, but lowered its annual projections. Salesforce shares dipped 6.7% to $167.95 in the after-hours trading session.
  • Analysts expect Dell Technologies Inc. (NYSE:DELL) to post quarterly earnings at $1.64 per share on revenue of $26.55 billion after the closing bell. Dell shares rose 0.9% to $47.06 in after-hours trading.
Total
0
Shares
Related Posts
Read More

Zealand Pharma Announced Global License and Development Agreement with Novo Nordisk for ZEGALOGUE; Zealand to Receive Upfront Payment of DKK 25M Plus Up to DKK 45M in Milestones

Zealand Pharma A/S (Nasdaq: ZEAL) (CVR-no. 20045078,) a biotechnology company focused on the discovery and development of innovative peptide-based medicines, today announced it has entered into a global license and development agreement with Novo Nordisk A/S to commercialize ZEGALOGUE® (dasiglucagon) for injection.

NVO